These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 23786932
1. Specific targeting of angiogenesis in lung cancer with RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a 4.7T magnetic resonance scanner. Liu C, Liu DB, Long GX, Wang JF, Mei Q, Hu GY, Qiu H, Hu GQ. Chin Med J (Engl); 2013 Jun; 126(12):2242-7. PubMed ID: 23786932 [Abstract] [Full Text] [Related]
2. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Zhang C, Jugold M, Woenne EC, Lammers T, Morgenstern B, Mueller MM, Zentgraf H, Bock M, Eisenhut M, Semmler W, Kiessling F. Cancer Res; 2007 Feb 15; 67(4):1555-62. PubMed ID: 17308094 [Abstract] [Full Text] [Related]
3. Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles. Cui Y, Zhang C, Luo R, Liu H, Zhang Z, Xu T, Zhang Y, Wang D. Int J Nanomedicine; 2016 Feb 15; 11():5671-5682. PubMed ID: 27895477 [Abstract] [Full Text] [Related]
4. RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment. Kiessling F, Huppert J, Zhang C, Jayapaul J, Zwick S, Woenne EC, Mueller MM, Zentgraf H, Eisenhut M, Addadi Y, Neeman M, Semmler W. Radiology; 2009 Nov 15; 253(2):462-9. PubMed ID: 19789239 [Abstract] [Full Text] [Related]
5. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice]. Wu QY, Shi JY, Zhang J, Zhang LQ, Zhao YM, Tang L, Chen Y, He XD, Liu H, Su B. Zhonghua Zhong Liu Za Zhi; 2013 Nov 15; 35(11):808-13. PubMed ID: 24447476 [Abstract] [Full Text] [Related]
7. Noninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scanner. Jiang T, Zhang C, Zheng X, Xu X, Xie X, Liu H, Liu S. Int J Nanomedicine; 2009 Nov 15; 4():241-9. PubMed ID: 20011241 [Abstract] [Full Text] [Related]
10. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model. Zhang C, Liu H, Cui Y, Li X, Zhang Z, Zhang Y, Wang D. Int J Nanomedicine; 2016 Nov 15; 11():1097-108. PubMed ID: 27051285 [Abstract] [Full Text] [Related]
16. Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice. Desestret V, Brisset JC, Moucharrafie S, Devillard E, Nataf S, Honnorat J, Nighoghossian N, Berthezène Y, Wiart M. Stroke; 2009 May 15; 40(5):1834-41. PubMed ID: 19286601 [Abstract] [Full Text] [Related]
17. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis. Xue S, Zhang C, Yang Y, Zhang L, Cheng D, Zhang J, Shi H, Zhang Y. J Biomed Nanotechnol; 2015 Jun 15; 11(6):1027-37. PubMed ID: 26353592 [Abstract] [Full Text] [Related]
18. Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma. Ma XH, Wang S, Liu SY, Chen K, Wu ZY, Li DF, Mi YT, Hu LB, Chen ZW, Zhao XM. World J Gastroenterol; 2019 Jun 28; 25(24):3030-3043. PubMed ID: 31293339 [Abstract] [Full Text] [Related]